Navigation Links
HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,,,Virus DNA


Single-tube amplification method for high-throughput screening of HSV

Cindy Walker-Peach Beti Belachew Peter Pingerelli Melanie Palmer Dwight DuBois
Stratagene

Stratagene introduces the HSVision molecular beacon detection module,*,,ff a single-tube method to quickly detect HSV (herpes simplex virus) DNA. Because it is performed in a closed-tube system and requires no postamplification manipulation, HSV detection is simplified, and the risk of contamination is markedly reduced. Using molecular beacon technology, this detection module includes an HSV molecular beacon that hybridizes to both HSV-1 and HSV-2 amplicons, a molecular beacon specific for an internal amplification control (IAC), a mixed HSV-1 and HSV-2 DNA standard, target-specific DNA primers, and an optimized PCR buffer. This module can be easily adapted for high-throughput screening

HSVs have worldwide distribution and cause a wide variety of illnesses in humans. Since this virus remains latent in the host for life, it can be reactivated to cause lesions at or near the site of initial infection.1 Most common are mucocutaneous infections, which primarily affect oral-facial and genital surfaces. However, more serious HSV infections can also involve the central nervous system and viscera, particularly in newborns and immunocompromised patients, where they are often life threatening. There are two HSV subtypes, HSV-1 and HSV-2,2 which are serologically and genetically distinct. HSV-1 and HSV-2 share a similar overall genomic structure and contain approximately 50% nucleotide sequence identity.

Current diagnostic methods for HSV infection include serological testing, viral culture, and more recently, PCR detection.3 Stratagene has developed a single-tube, real-
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
2. Genotyping Single Nucleotide Polymorphisms with Molecular Beacons
3. New Protocols for Isolating High- Molecular-Weight Genomic DNA
4. Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation
5. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
6. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
7. Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers
8. Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)
9. Near Infrared Technology and Optical Agents For Molecular Imaging
10. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
11. A New PCR-based Mycoplasma Detection Method
Post Your Comments:
(Date:12/16/2009)... The American Filtration and Separations Society will hold its 23rd Annual ... Hyatt Hotel in San Antonio, Texas. To further impact the separation ... we are proud to announce that the 2010 AFS Annual Technical ... , , ... Minneapolis, MN (PRWEB) December 16, 2009 ...
(Date:12/15/2009)... -- Repligen Corporation (Nasdaq: RGEN ) today ... research funding to support the ongoing development of ... Dystrophy Association (MDA). This grant will support ... GMP manufacture of a drug candidate for human ... only provides important funding for Repligen,s research but ...
(Date:12/15/2009)... -- Aethlon Medical, Inc. (OTC Bulletin Board : ... Dr. Wayne Comper have joined the ... Both Dr. Schorey and Dr. Comper are leading ... owned subsidiary of Aethlon Medical, was recently formed ... medical device being advanced as an adjunct therapy ...
(Date:12/15/2009)... 15 The Mosaic Company (NYSE: MOS ... 2010 earnings results and financial tables on Tuesday, January ... New York Stock Exchange. Results will be available ... Company will host a conference call with presentation slides ... The call will begin at 11:00 a.m. Eastern ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... BEIJING, March 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE ... of vaccines in,China, announced today that the Chinese ... of China, the Ministry of Finance and the ... subsidiary,Sinovac Biotech Co. Ltd.(Sinovac Beijing), high-tech enterprise status.,According ...
... Spectral Diagnostics Inc. (TSX:SDI) today announced that it ... Inc. of Japan granting Spectral the exclusive development ... a therapeutic device for the treatment of sepsis ... terms of the agreement, Spectral will seek FDA ...
... March 9 MannKind Corporation (Nasdaq: MNKD ... with Pfizer Inc. (NYSE: PFE ) to ... Main, Germany and assets related to the production of ... production equipment, a quantity of bulk insulin and a ...
Other Biology Technology:Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status 2Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status 3Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market 2Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market 3MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant 2MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant 3MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant 4
(Date:12/15/2009)... at VIB and Ghent University in Flanders, Belgium have ... shock, the major cause of death in intensive care ... gas in mice with septic shock, researchers Anje Cauwels ... much less damage, while their chances of survival increased ... generally assumed that nitric oxide is responsible for the ...
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
(Date:12/15/2009)... and economic toll on society. It is estimated that ... in U.S. waters and it,s likely that rip currents account ... disconnect exists between rip current research and public understanding. ... and more importantly, most people do not know how to ... The goal of the Rip Current Symposium is to identify ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Lumetra Announces Sale of Subsidiary IntegriGuard 58553 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 3Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 4Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 5Blue Belt Technologies Inc Closes Series A Financing 5111 1Blue Belt Technologies Inc Closes Series A Financing 5111 2Blue Belt Technologies Inc Closes Series A Financing 5111 3
... features of a living organism. An external or internal ... genes whose activity turns on or off various biological ... repair, cellular suicide etc). Many of the regulatory functions ... to 6 - 10 nucleotide long binding sequences located ...
... Capuchin monkeys are playful, inquisitive primates known for ... New research now shows that just like humans, ... of the brain, specifically in the corpus callosum, the ... , A recently published paper by Associate Professor of ...
... of world population is infected with hepatitis C virus (HCV). ... chronic hepatitis, and many of the chronic infections will develop ... cure for chronic hepatitis C, nor is there any approved ... health problem worldwide. , Twenty to fifty percent of HCV ...
Other Biology News:Gene regulation in humans is closer than expected to simple organisms 2Influence of sex and handedness on brain is similar in capuchin monkeys and humans 2Who will recover spontaneously from hepatitis C virus infection 2
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products: